Clinical Trials Browser

Embolism, Neoplasms, Venous Thromboembolism

NCT07439991 2026-02-27

Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery

Recruiting

900 enrolled

Classical hematologyThoracic

Disease, Lung Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT07310693 2025-12-30

CLOVER

Recruiting

500 enrolled

Classical hematology

Venous Thromboembolism

NCT07288632 2025-12-17

Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer

Recruiting

500 enrolled

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Venous Thromboembolism

NCT07196020 2025-09-29

PINPOINT

Not yet recruiting

380 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT06672250 2025-09-24

The Correlation Between Circulatory Tumor Cells and Venous Thrombosis

Recruiting

120 enrolled

Classical hematology

Neoplastic Cells, Circulating, Neoplasms, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT07008508 2025-06-06

BRAVE-Cyclin

Active not recruiting

300 enrolled

BreastClassical hematology

Breast Neoplasms, Cardiovascular Diseases, Venous Thromboembolism

NCT06952062 2025-05-04

CARDIO-COM

Active not recruiting

2,400 enrolled

Classical hematology

Cardiovascular Diseases, Hemorrhage, Neoplasms, Venous Thromboembolism

NCT06950697 2025-04-30

Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

Recruiting

2,400 enrolled

Classical hematologyThoracic

Lung Neoplasms, Venous Thromboembolism

Clinical Trials

VICTORIE

Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery

CLOVER

Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer

PINPOINT

The Correlation Between Circulatory Tumor Cells and Venous Thrombosis

BRAVE-Cyclin

CARDIO-COM

Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors